143 related articles for article (PubMed ID: 36459061)
1. Significance of Statin-Associated Muscle Symptoms and Its Impact on Patients Adherence and Outcomes.
Al-Makhamreh HK; Toubasi AA; Obaid YY; Albustanji FH
J Cardiovasc Pharmacol; 2023 Mar; 81(3):185-191. PubMed ID: 36459061
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 supplementation for the treatment of statin-associated muscle symptoms.
Chen W; Ochs-Balcom HM; Ma C; Isackson PJ; Vladutiu GD; Luzum JA
Future Cardiol; 2022 Jun; 18(6):461-470. PubMed ID: 35297269
[TBL] [Abstract][Full Text] [Related]
3. The Statin-Associated Muscle Symptom Clinical Index (SAMS-CI): Revision for Clinical Use, Content Validation, and Inter-rater Reliability.
Rosenson RS; Miller K; Bayliss M; Sanchez RJ; Baccara-Dinet MT; Chibedi-De-Roche D; Taylor B; Khan I; Manvelian G; White M; Jacobson TA
Cardiovasc Drugs Ther; 2017 Apr; 31(2):179-186. PubMed ID: 28421332
[TBL] [Abstract][Full Text] [Related]
4. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
[TBL] [Abstract][Full Text] [Related]
5. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
[TBL] [Abstract][Full Text] [Related]
6. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
Taylor BA; Thompson PD
Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
[TBL] [Abstract][Full Text] [Related]
7. Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels.
Carallo C; Capozza A; Gnasso A
Metab Syndr Relat Disord; 2022 Dec; 20(10):567-575. PubMed ID: 36346279
[No Abstract] [Full Text] [Related]
8. Switching, Persistence and Adherence to Statin Therapy: a Retrospective Cohort Study Using the Australian National Pharmacy Data.
Talic S; Marquina C; Ofori-Asenso R; Petrova M; Liew D; Owen AJ; Lybrand S; Thomson D; Ilomaki J; Zomer E; Ademi Z
Cardiovasc Drugs Ther; 2022 Oct; 36(5):867-877. PubMed ID: 34097194
[TBL] [Abstract][Full Text] [Related]
9. Muscle and statins: from toxicity to the nocebo effect.
Pedro-Botet J; Climent E; Benaiges D
Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
[TBL] [Abstract][Full Text] [Related]
10. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
11. Trial designs for statin muscle intolerance.
Rosenson RS
Curr Opin Lipidol; 2017 Dec; 28(6):488-494. PubMed ID: 28832369
[TBL] [Abstract][Full Text] [Related]
12. The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs.
Herrett E; Williamson E; Brack K; Perkins A; Thayne A; Shakur-Still H; Roberts I; Prowse D; Beaumont D; Jamal Z; Goldacre B; van Staa T; MacDonald TM; Armitage J; Moore M; Hoffman M; Smeeth L
Health Technol Assess; 2021 Mar; 25(16):1-62. PubMed ID: 33709907
[TBL] [Abstract][Full Text] [Related]
13. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
[TBL] [Abstract][Full Text] [Related]
14. Impact of statin withdrawal on perceived and objective muscle function.
Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Dufresne SS; Huth C; Bergeron J; Joanisse DR
PLoS One; 2023; 18(6):e0281178. PubMed ID: 37315062
[TBL] [Abstract][Full Text] [Related]
15. Statins and musculoskeletal conditions, arthropathies, and injuries.
Mansi I; Frei CR; Pugh MJ; Makris U; Mortensen EM
JAMA Intern Med; 2013 Jul; 173(14):1-10. PubMed ID: 23877079
[TBL] [Abstract][Full Text] [Related]
16. Statin intolerance.
Laufs U; Scharnagl H; März W
Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
[TBL] [Abstract][Full Text] [Related]
17. Statin withdrawal and health-related quality of life in a primary cardiovascular prevention cohort.
Peyrel P; Mauriège P; Frenette J; Laflamme N; Greffard K; Huth C; Bergeron J; Joanisse DR
Qual Life Res; 2023 Jul; 32(7):1943-1954. PubMed ID: 36781811
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial.
Murphy WA; Lin N; Damask A; Schwartz GG; Steg PG; Szarek M; Banerjee P; Fazio S; Manvelian G; Pordy R; Shuldiner AR; Paulding C
Circ Genom Precis Med; 2022 Jun; 15(3):e003503. PubMed ID: 35543701
[TBL] [Abstract][Full Text] [Related]
19. Low vitamin D does not predict statin associated muscle symptoms but is associated with transient increases in muscle damage and pain.
Taylor BA; Lorson L; White CM; Thompson PD
Atherosclerosis; 2017 Jan; 256():100-104. PubMed ID: 27993387
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol - A Cross-sectional Study.
Kaur H; Singh J; Kashyap JR; Rohilla R; Singh H; Jaswal S; Kumar R
Eur Endocrinol; 2020 Oct; 16(2):137-142. PubMed ID: 33117445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
